Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increasing the impact of vertebrate scientific collections through 3D imaging: The openVertebrate (oVert) Thematic Collections Network.
Blackburn DC, Boyer DM, Gray JA, Winchester J, Bates JM, Baumgart SL, Braker E, Coldren D, Conway KW, Rabosky AD, de la Sancha N, Dillman CB, Dunnum JL, Early CM, Frable BW, Gage MW, Hanken J, Maisano JA, Marks BD, Maslenikov KP, McCormack JE, Nagesan RS, Pandelis GG, Prestridge HL, Rabosky DL, Randall ZS, Robbins MB, Scheinberg LA, Spencer CL, Summers AP, Tapanila L, Thompson CW, Tornabene L, Watkins-Colwell GJ, Welton LJ; oVert Project Team; Stanley EL. Blackburn DC, et al. Bioscience. 2024 Mar 6;74(3):169-186. doi: 10.1093/biosci/biad120. eCollection 2024 Mar. Bioscience. 2024. PMID: 38560620 Free PMC article. Review.
Metabolic model predictions enable targeted microbiome manipulation through precision prebiotics.
Marinos G, Hamerich IK, Debray R, Obeng N, Petersen C, Taubenheim J, Zimmermann J, Blackburn D, Samuel BS, Dierking K, Franke A, Laudes M, Waschina S, Schulenburg H, Kaleta C. Marinos G, et al. Among authors: blackburn d. Microbiol Spectr. 2024 Feb 6;12(2):e0114423. doi: 10.1128/spectrum.01144-23. Epub 2024 Jan 17. Microbiol Spectr. 2024. PMID: 38230938 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Mummery CJ, Börjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S, Jonsson M, Schneider A, Rinne JO, Ludolph AC, Bodenschatz R, Kordasiewicz H, Swayze EE, Fitzsimmons B, Mignon L, Moore KM, Yun C, Baumann T, Li D, Norris DA, Crean R, Graham DL, Huang E, Ratti E, Bennett CF, Junge C, Lane RM. Mummery CJ, et al. Among authors: blackburn dj. Nat Med. 2024 Jan;30(1):304. doi: 10.1038/s41591-023-02639-3. Nat Med. 2024. PMID: 37845513 Free PMC article. No abstract available.
516 results